Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 639

1.

CMV seropositivity is associated with increased microbial translocation in people living with HIV and uninfected controls.

Ramendra R, Isnard S, Lin J, Fombuena B, Ouyang J, Mehraj V, Zhang Y, Finkelman M, Costiniuk C, Lebouché B, Chartrand-Lefebvre C, Durand M, Tremblay C, Ancuta P, Boivin G, Routy JP.

Clin Infect Dis. 2019 Oct 14. pii: ciz1001. doi: 10.1093/cid/ciz1001. [Epub ahead of print]

PMID:
31608409
2.

Impact of the baloxavir-resistant polymerase acid (PA) I38T substitution on the fitness of contemporary influenza A(H1N1)pdm09 and A(H3N2) strains.

Checkmahomed L, M'hamdi Z, Carbonneau J, Venable MC, Baz M, Abed Y, Boivin G.

J Infect Dis. 2019 Aug 16. pii: jiz418. doi: 10.1093/infdis/jiz418. [Epub ahead of print]

PMID:
31419295
3.

Bone remodeling and bone matrix quality before and after menopause in healthy women.

Farlay D, Bala Y, Rizzo S, Bare S, Lappe JM, Recker R, Boivin G.

Bone. 2019 Aug 9;128:115030. doi: 10.1016/j.bone.2019.08.003. [Epub ahead of print]

PMID:
31404670
4.

Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia.

Nicolas de Lamballerie C, Pizzorno A, Dubois J, Julien T, Padey B, Bouveret M, Traversier A, Legras-Lachuer C, Lina B, Boivin G, Terrier O, Rosa-Calatrava M.

Sci Rep. 2019 Aug 7;9(1):11493. doi: 10.1038/s41598-019-48013-7.

5.

Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).

LeBlanc JJ, ElSherif M, Ye L, MacKinnon-Cameron D, Ambrose A, Hatchette TF, Lang ALS, Gillis HD, Martin I, Demczuk W, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, McCarthy AE, McGeer A, Semret M, Trottier S, Valiquette L, Webster D, McNeil SA.

Vaccine. 2019 Aug 23;37(36):5466-5473. doi: 10.1016/j.vaccine.2019.05.003. Epub 2019 Jul 23.

6.

The Val430Ile neuraminidase (NA) substitution, identified in influenza B virus isolates, impacts the catalytic 116Arg residue causing reduced susceptibility to NA inhibitors.

Abed Y, Fage C, Checkmahomed L, Begin G, Carbonneau J, Lague P, Boivin G.

Antiviral Res. 2019 Oct;170:104561. doi: 10.1016/j.antiviral.2019.104561. Epub 2019 Jul 16.

PMID:
31323237
7.

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults.

LeBlanc JJ, ElSherif M, Mulpuru S, Warhuus M, Ambrose A, Andrew M, Boivin G, Bowie W, Chit A, Dos Santos G, Green K, Halperin SA, Hatchette TF, Ibarguchi B, Johnstone J, Katz K, Langley JM, Lagacé-Wiens P, Loeb M, Lund A, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA.

J Med Microbiol. 2019 Jul 2. doi: 10.1099/jmm.0.001032. [Epub ahead of print]

PMID:
31264957
8.

Antiviral Agents in Development for Zika Virus Infections.

Baz M, Boivin G.

Pharmaceuticals (Basel). 2019 Jun 29;12(3). pii: E101. doi: 10.3390/ph12030101. Review.

9.

Compartmentalization of a Multidrug-Resistant Cytomegalovirus UL54 Mutant in a Stem Cell Transplant Recipient with Encephalitis.

Piret J, Schibler M, Pham VD, Hantz S, Giannotti F, Masouridi-Levrat S, Kaiser L, Goyette N, Alain S, Shi R, Boivin G.

J Infect Dis. 2019 Sep 13;220(8):1302-1306. doi: 10.1093/infdis/jiz298.

PMID:
31199457
10.

Human metapneumovirus activates NOD-like receptor protein 3 inflammasome via its small hydrophobic protein which plays a detrimental role during infection in mice.

Lê VB, Dubois J, Couture C, Cavanagh MH, Uyar O, Pizzorno A, Rosa-Calatrava M, Hamelin MÈ, Boivin G.

PLoS Pathog. 2019 Apr 9;15(4):e1007689. doi: 10.1371/journal.ppat.1007689. eCollection 2019 Apr.

11.

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada.

Abed Y, Fage C, Lagüe P, Carbonneau J, Papenburg J, Vinh DC, Boivin G.

Emerg Infect Dis. 2019 Apr;25(4):838-840. doi: 10.3201/eid2504.181554.

12.

Design and Validation with Influenza A Virus of an Aerosol Transmission Chamber for Ferrets.

Turgeon N, Hamelin MÈ, Verreault D, Lévesque A, Rhéaume C, Carbonneau J, Checkmahomed L, Girard M, Boivin G, Duchaine C.

Int J Environ Res Public Health. 2019 Feb 19;16(4). pii: E609. doi: 10.3390/ijerph16040609.

13.

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.

Pizzorno A, Terrier O, Nicolas de Lamballerie C, Julien T, Padey B, Traversier A, Roche M, Hamelin ME, Rhéaume C, Croze S, Escuret V, Poissy J, Lina B, Legras-Lachuer C, Textoris J, Boivin G, Rosa-Calatrava M.

Front Immunol. 2019 Jan 29;10:60. doi: 10.3389/fimmu.2019.00060. eCollection 2019.

14.

The recruitment of peripheral blood leukocytes to the brain is delayed in susceptible BALB/c compared to resistant C57BL/6 mice during herpes simplex virus encephalitis.

Canivet C, Uyar O, Rhéaume C, Piret J, Boivin G.

J Neurovirol. 2019 Jun;25(3):372-383. doi: 10.1007/s13365-019-00730-5. Epub 2019 Feb 13.

PMID:
30758810
15.

OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes.

Del Campo J, Pizzorno A, Djebali S, Bouley J, Haller M, Pérez-Vargas J, Lina B, Boivin G, Hamelin ME, Nicolas F, Le Vert A, Leverrier Y, Rosa-Calatrava M, Marvel J, Hill F.

NPJ Vaccines. 2019 Jan 23;4:4. doi: 10.1038/s41541-019-0098-4. eCollection 2019.

16.

Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance.

Piret J, Boivin G.

Antiviral Res. 2019 Mar;163:91-105. doi: 10.1016/j.antiviral.2019.01.011. Epub 2019 Jan 25. Review.

PMID:
30690043
17.

The Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4.

Dubois J, Traversier A, Julien T, Padey B, Lina B, Bourdon JC, Marcel V, Boivin G, Rosa-Calatrava M, Terrier O.

J Virol. 2019 Mar 21;93(7). pii: e02168-18. doi: 10.1128/JVI.02168-18. Print 2019 Apr 1.

18.

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.

Mulpuru S, Li L, Ye L, Hatchette T, Andrew MK, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Chest. 2019 Jan;155(1):69-78. doi: 10.1016/j.chest.2018.10.044.

PMID:
30616737
19.

In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors.

Fage C, Abed Y, Checkmahomed L, Venable MC, Boivin G.

Viruses. 2018 Dec 22;11(1). pii: E6. doi: 10.3390/v11010006.

20.

Prevalence of a nematode castrator of the carrot weevil and impact on fecundity and survival.

Gagnon AÈ, Boivin G, Bélair G, Mimee B.

Parasitology. 2018 Dec 20:1-6. doi: 10.1017/S0031182018002056. [Epub ahead of print]

PMID:
30567618
21.

The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.

Nichols MK, Andrew MK, Ye L, Hatchette TF, Ambrose A, Boivin G, Bowie W, Dos Santos G, Elsherif M, Green K, Haguinet F, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Sharma R, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Clin Infect Dis. 2019 Aug 30;69(6):970-979. doi: 10.1093/cid/ciy1009.

PMID:
30508064
22.

Molecular and epidemiologic investigation of a rhinovirus outbreak in a neonatal intensive care unit.

El Idrissi KR, Isabel S, Carbonneau J, Lafond M, Quach C, Caya C, Fontela PS, Beltempo M, Boivin G, Lefebvre MA, Papenburg J.

Infect Control Hosp Epidemiol. 2019 Feb;40(2):245-247. doi: 10.1017/ice.2018.311. Epub 2018 Dec 5.

PMID:
30516128
23.

Variables Reflecting the Mineralization of Bone Tissue From Fracturing Versus Nonfracturing Postmenopausal Nonosteoporotic Women.

Rizzo S, Farlay D, Akhter M, Boskey A, Recker R, Lappe J, Boivin G.

JBMR Plus. 2018 Jun 20;2(6):323-327. doi: 10.1002/jbm4.10062. eCollection 2018 Nov.

24.
25.

Comparison of early and recent influenza A(H1N1)pdm09 isolates harboring or not the H275Y neuraminidase mutation, in vitro and in animal models.

Abed Y, Tu V, Carbonneau J, Checkmahomed L, Venable MC, Fage C, Marie-Ève-Hamelin, Dufresne SF, Kobinger G, Boivin G.

Antiviral Res. 2018 Nov;159:26-34. doi: 10.1016/j.antiviral.2018.09.007. Epub 2018 Sep 13.

PMID:
30219318
26.

The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.

Bolduc M, Baz M, Laliberté-Gagné MÈ, Carignan D, Garneau C, Russel A, Boivin G, Savard P, Leclerc D.

Nanomedicine. 2018 Nov;14(8):2563-2574. doi: 10.1016/j.nano.2018.08.010. Epub 2018 Sep 5.

PMID:
30193813
27.

Evaluation of anticoagulant agents for the treatment of human metapneumovirus infection in mice.

Lê BV, Jandrot-Perrus M, Couture C, Checkmahomed L, Venable MC, Hamelin MÈ, Boivin G.

J Gen Virol. 2018 Oct;99(10):1367-1380. doi: 10.1099/jgv.0.001135. Epub 2018 Aug 10.

PMID:
30102144
28.

Both IRF3 and especially IRF7 play a key role to orchestrate an effective cerebral inflammatory response in a mouse model of herpes simplex virus encephalitis.

Canivet C, Rhéaume C, Lebel M, Piret J, Gosselin J, Boivin G.

J Neurovirol. 2018 Dec;24(6):761-768. doi: 10.1007/s13365-018-0666-9. Epub 2018 Aug 9.

PMID:
30094631
29.

Zika-Induced Male Infertility in Mice Is Potentially Reversible and Preventable by Deoxyribonucleic Acid Immunization.

de La Vega MA, Piret J, Griffin BD, Rhéaume C, Venable MC, Carbonneau J, Couture C, das Neves Almeida R, Tremblay RR, Magalhães KG, Park YK, Roberts CC, Maslow JN, Sardesai NY, Kim JJ, Muthumani K, Weiner DB, Kobinger GP, Boivin G.

J Infect Dis. 2019 Jan 9;219(3):365-374. doi: 10.1093/infdis/jiy336.

PMID:
30053014
30.

Cellular Composition and Contribution of Tertiary Lymphoid Structures to Tumor Immune Infiltration and Modulation by Radiation Therapy.

Boivin G, Kalambaden P, Faget J, Rusakiewicz S, Montay-Gruel P, Meylan E, Bourhis J, Lesec G, Vozenin MC.

Front Oncol. 2018 Jul 9;8:256. doi: 10.3389/fonc.2018.00256. eCollection 2018.

31.

Ovigeny index increases with temperature in an aphid parasitoid: Is early reproduction better when it is hot?

Moiroux J, Boivin G, Brodeur J.

J Insect Physiol. 2018 Aug - Sep;109:157-162. doi: 10.1016/j.jinsphys.2018.06.001. Epub 2018 Jun 2.

PMID:
29870689
32.

Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses.

Tu V, Abed Y, Fage C, Baz M, Boivin G.

Antiviral Res. 2018 Jun;154:110-115. doi: 10.1016/j.antiviral.2018.04.009. Epub 2018 Apr 16.

PMID:
29674164
33.

Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis.

Dempster DW, Brown JP, Fahrleitner-Pammer A, Kendler D, Rizzo S, Valter I, Wagman RB, Yin X, Yue SV, Boivin G.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2498-2509. doi: 10.1210/jc.2017-02669.

34.

Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention.

Martín-López J, Gasparini P, Coombes K, Croce CM, Boivin GP, Fishel R.

Oncotarget. 2017 Dec 31;9(16):12554-12561. doi: 10.18632/oncotarget.23792. eCollection 2018 Feb 27.

35.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

Nichols MK, Andrew MK, Hatchette TF, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Lagacé-Wiens P, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Schuind A, Semret M, Shinde V, Smith S, Smyth D, Stiver G, Taylor G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN), the Toronto Invasive Bacterial Diseases Network (TIBDN).

Vaccine. 2018 Apr 12;36(16):2166-2175. doi: 10.1016/j.vaccine.2018.02.093. Epub 2018 Mar 13.

PMID:
29548608
36.

Plane Wave SH₀ Piezoceramic Transduction Optimized Using Geometrical Parameters.

Boivin G, Viens M, Belanger P.

Sensors (Basel). 2018 Feb 10;18(2). pii: E542. doi: 10.3390/s18020542.

37.
38.

Predominant role of IPS-1 over TRIF adaptor proteins in early innate immune response against Zika virus in mice.

Piret J, Carbonneau J, Rhéaume C, Baz M, Boivin G.

J Gen Virol. 2018 Feb;99(2):209-218. doi: 10.1099/jgv.0.000992. Epub 2018 Jan 3.

PMID:
29297844
39.

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.

Andrew MK, Shinde V, Hatchette T, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Nichols MK, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network and the Toronto Invasive Bacterial Diseases Network (TIBDN).

BMC Infect Dis. 2017 Dec 29;17(1):805. doi: 10.1186/s12879-017-2905-8.

40.

Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer.

Faget J, Groeneveld S, Boivin G, Sankar M, Zangger N, Garcia M, Guex N, Zlobec I, Steiner L, Piersigilli A, Xenarios I, Meylan E.

Cell Rep. 2017 Dec 12;21(11):3190-3204. doi: 10.1016/j.celrep.2017.11.052.

41.

Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network.

Ng C, Ye L, Noorduyn SG, Hux M, Thommes E, Goeree R, Ambrose A, Andrew MK, Hatchette T, Boivin G, Bowie W, ElSherif M, Green K, Johnstone J, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Poirier A, Powis J, Richardson D, Sharma R, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN) Investigators; Toronto Invasive Bacterial Diseases Network (TIBDN) Investigators.

Influenza Other Respir Viruses. 2018 Mar;12(2):232-240. doi: 10.1111/irv.12521. Epub 2018 Jan 24.

42.

Protease-activated receptor 1 inhibition protects mice against thrombin-dependent respiratory syncytial virus and human metapneumovirus infections.

Lê VB, Riteau B, Alessi MC, Couture C, Jandrot-Perrus M, Rhéaume C, Hamelin MÈ, Boivin G.

Br J Pharmacol. 2018 Jan;175(2):388-403. doi: 10.1111/bph.14084. Epub 2017 Dec 10.

43.

Type 1 primary hyperoxaluria: A case report and focus on bone impairment of systemic oxalosis.

Pijnenburg L, Caillard S, Boivin G, Rizzo S, Javier RM.

Morphologie. 2018 Mar;102(336):48-53. doi: 10.1016/j.morpho.2017.09.004. Epub 2018 Feb 22.

PMID:
29102553
44.

Peramivir susceptibilities of recombinant influenza A and B variants selected with various neuraminidase inhibitors.

Fage C, Tu V, Carbonneau J, Abed Y, Boivin G.

Antivir Ther. 2017;22(8):711-716. doi: 10.3851/IMP3158.

PMID:
29082897
45.

Behavioural effects of temperature on ectothermic animals: unifying thermal physiology and behavioural plasticity.

Abram PK, Boivin G, Moiroux J, Brodeur J.

Biol Rev Camb Philos Soc. 2017 Nov;92(4):1859-1876. doi: 10.1111/brv.12312. Epub 2016 Nov 7.

PMID:
28980433
46.

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.

Andrew MK, Shinde V, Ye L, Hatchette T, Haguinet F, Dos Santos G, McElhaney JE, Ambrose A, Boivin G, Bowie W, Chit A, ElSherif M, Green K, Halperin S, Ibarguchi B, Johnstone J, Katz K, Langley J, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McGeer A, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) and the Toronto Invasive Bacterial Diseases Network (TIBDN).

J Infect Dis. 2017 Aug 15;216(4):405-414. doi: 10.1093/infdis/jix282.

47.

Physiologic, Behavioral, and Histologic Responses to Various Euthanasia Methods in C57BL/6NTac Male Mice.

Boivin GP, Bottomley MA, Schiml PA, Goss L, Grobe N.

J Am Assoc Lab Anim Sci. 2017 Jan 1;56(1):69-78.

48.

Review of CO₂ as a Euthanasia Agent for Laboratory Rats and Mice.

Boivin GP, Hickman DL, Creamer-Hente MA, Pritchett-Corning KR, Bratcher NA.

J Am Assoc Lab Anim Sci. 2017 Sep 1;56(5):491-499. Review.

49.

A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir.

Abed Y, Boivin G.

Open Forum Infect Dis. 2017 May 18;4(3):ofx105. doi: 10.1093/ofid/ofx105. eCollection 2017 Summer. Review.

50.

Drug Susceptibility and Replicative Capacity of Multidrug-Resistant Recombinant Human Cytomegalovirus Harboring Mutations in UL56 and UL54 Genes.

Piret J, Goyette N, Boivin G.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01044-17. doi: 10.1128/AAC.01044-17. Print 2017 Nov.

Supplemental Content

Loading ...
Support Center